Esperion Therapeutics Inc Ne shares owned by Context Capital Management
Quarter-by-quarter ownership of Esperion Therapeutics Inc Ne shares owned by Context Capital Management
from 13F filings
Historical chart of Context Capital Management investment in Esperion Therapeutics Inc Ne
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics Inc Ne held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Esperion Therapeutics Inc Ne by Context Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $46M | 48k | 953.13 |
2024-06-30 | $48M | 51k | 932.50 |
2024-03-31 | $32M | 38k | 835.56 |
2023-12-31 | $11B | 18M | 593.26 |
2023-09-30 | $9.3M | 18k | 520.87 |
2023-06-30 | $11M | 21k | 496.89 |
2023-03-31 | $8.8M | 22k | 401.08 |
2022-12-31 | $6.7M | 12k | 549.98 |
2022-09-30 | $8.3M | 15k | 560.42 |
2022-06-30 | $8.1M | 15k | 550.73 |
2022-03-31 | $8.6M | 16k | 527.91 |
2021-12-31 | $9.9M | 19k | 527.98 |
More positions owned by Context Capital Management
View all positions for Context Capital Management